Sector: Industrials | Industry: Environmental Services & Equipment |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 380 Lackawanna Pl SOUTH ORANGE NJ 07079-1704 |
Tel: | N/A |
Website: | https://www.nephros.com |
IR: | See website |
Key People | ||
Robert Banks President, Chief Executive Officer, Director | Judy Krandel Chief Financial Officer |
Business Overview |
Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. It operates through the Water Filtration segment. In the medical markets, it sells water filtration products. In the commercial markets, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. Its products are marketed primarily to the food service, hospitality, convenience store, and health care markets. These commercial products are also marketed into medical markets, as supplemental filtration to its medical filters. The Company's filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate. |
Financial Overview |
For the fiscal year ended 31 December 2023, Nephros Inc revenues increased 43% to $14.2M. Net loss before extraordinary items decreased 65% to $1.6M. Revenues reflect Licensing revenues increase from $46K to $128K. Lower net loss reflects Research and Development - Balancing val decrease of 29% to $834K (expense), Interest Income increase from $14K to $64K (income), Stock-Based Comp in R&D decrease of 38% to $39K (expense). |
Employees: | 31 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $17.84M as of Dec 31, 2023 |
Annual revenue (TTM): | $14.24M as of Dec 31, 2023 |
EBITDA (TTM): | -$1.38M as of Dec 31, 2023 |
Net annual income (TTM): | -$1.58M as of Dec 31, 2023 |
Free cash flow (TTM): | $0.75M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 10,544,139 as of Apr 2, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |